Join
Live feed
·
INSIDERFilingvia Quantisnow
Syndax Pharmaceuticals Inc. logo

Head of R&D, CMO Botwood Nicholas A.J. exercised 53,750 shares at a strike of $13.82 and sold $1,183,643 worth of shares (65,515 units at $18.07) as part of a pre-agreed trading plan, decreasing direct ownership by 16% to 60,885 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNDX (Syndax Pharmaceuticals Inc.) and more on Quantisnow.